Prescription drug · ANDA
Meloxicam NDC 71610-881
Meloxicam 7.5 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-881-30 | 71610088130 | 30 TABLET in 1 BOTTLE (71610-881-30)Marketed from Feb 20, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Meloxicam
- Generic name (nonproprietary)
- meloxicam
- Active ingredients
- Meloxicam — 7.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077920
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 71610-881_2eaaaae3-9819-9201-e063-6394a90a94c3SPL ID 2eaaaae3-9819-9201-e063-6394a90a94c3SPL set ID 2eaac8b2-d50a-a0bc-e063-6294a90a7cacRxCUI 311486UNII VG2QF83CGL
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610088130followed by a unit qualifier and the quantityPackage 71610-0881-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
1. INDICATIONS AND USAGE Meloxicam tablets are a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) (1.1) Rheumatoid Arthritis (RA) (1.2) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg (1.3) 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see Clinical Studies (14.1)]. 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see Clinical Studies (14.1)]. 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or poly…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077920
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | AiPing Pharmaceutical, Inc | 11788-099 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc | 11788-098 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Medcore LLC | 82461-712 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Medcore LLC | 82461-719 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-872 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-403 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-402 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc | 11788-046 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | AiPing Pharmaceutical, Inc | 11788-047 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-447 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-446 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Chartwell RX, LLC | 62135-716 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Chartwell RX, LLC | 62135-715 |